ウイルス検体採集市場- 世界の産業規模、シェア、動向、機会、予測：製品タイプ別、サンプル別、地域別セグメント、競合、2020年～2030年

世界のウイルス検体採集市場は、2024年に65億米ドルと評価され、予測期間中にCAGR 4.51％で成長し、2030年には84億7,000万米ドルに達すると予測されています。

同市場は、イムノアッセイ、核酸増幅技術、PCR法、質量分析、次世代シーケンシング（NGS）など、さまざまなウイルス感染症に対する迅速かつ正確な診断を目的とした検体採取技術の進歩によって推進されています。さらに、製薬・バイオ医薬品セクターにおける研究開発への投資の増加が需要をさらに押し上げています。バイオ医薬品における高分子医薬品開発への注目の高まりも、今後数年間の市場拡大に寄与しています。

市場促進要因

世界のウイルス感染の増加

主な市場課題

品質管理と標準化の問題

主な市場動向

検体ハンドリングの自動化とデジタル化

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界のウイルス検体採集市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 製品タイプ別（ウイルス輸送培地、検体採取チューブ、スワブ、採血キット）
  • サンプル別（血液サンプル、頸部サンプル、鼻腔サンプル、鼻咽頭サンプル、咽喉サンプル、口腔サンプル、その他のサンプル）
  • 地域別（北米、欧州、アジア太平洋、南米、中東・アフリカ）
  • 企業別（2024）
• 市場マップ
• 製品タイプ別
• サンプル別
• 地域別

第6章 北米のウイルス検体採集市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州のウイルス検体採集市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第8章 アジア太平洋地域のウイルス検体採集市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米のウイルス検体採集市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカのウイルス検体採集市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 合併と買収
• 製品上市

第13章 世界のウイルス検体採集市場：SWOT分析

第14章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第15章 競合情勢

• Becton, Dickinson and Company
• Quidel Corporation
• Thermo Fisher Scientific Inc.
• Trinity Biotech PLC
• Titan Biotech Ltd.
• DiaSorin S.p.A.
• Vircell S.L.
• Copan Italia S.P.A.
• Puritan Medical Products Co.
• Hardy Diagnostics

第16章 戦略的提言

第17章 調査会社について・免責事項

The Global Virology Specimen Collection Market was valued at USD 6.50 billion in 2024 and is projected to reach USD 8.47 billion by 2030, growing at a CAGR of 4.51% during the forecast period. The market is being propelled by advancements in specimen collection technologies such as immunoassays, nucleic acid amplification techniques, PCR methods, mass spectrometry, and next-generation sequencing (NGS), all aimed at delivering fast and accurate diagnostics for various viral infections. In addition, increasing investment in research and development within the pharmaceutical and biopharmaceutical sectors is further driving demand. The growing focus on large molecule drug development in biopharmaceuticals is also contributing to the market's expansion over the coming years.

Key Market Drivers

Rising Global Burden of Viral Infections

The growing prevalence and recurrence of viral infections worldwide are key factors accelerating the virology specimen collection market. Conditions such as HIV, hepatitis, influenza, respiratory syncytial virus (RSV), and the recent emergence of COVID-19 necessitate reliable diagnostic practices that begin with high-quality specimen collection. According to the World Health Organization (WHO), seasonal influenza alone causes between 290,000 and 650,000 respiratory deaths annually. Additionally, WHO's 2023 hepatitis report revealed that 254 million people are living with chronic hepatitis B and 50 million with hepatitis C. These figures highlight the critical need for ongoing viral load testing and effective sample collection protocols to support timely diagnosis and treatment.

Key Market Challenges

Quality Control and Standardization Issues

Ensuring consistent quality and standardization in specimen collection across varied environments presents a significant challenge, particularly in low-resource or high-demand outbreak situations. Accurate diagnostic outcomes depend on the integrity of the specimen from collection to analysis, which can be compromised by inconsistent handling procedures, equipment variation, and lack of trained personnel. Although global agencies like WHO and CDC have outlined standard operating procedures, adherence remains uneven-especially in community-level or decentralized settings. For instance, WHO's guidance during the COVID-19 pandemic stressed that improper specimen collection contributed to false-negative results, even in high-income countries. Challenges such as incorrect swab usage or inadequate temperature control during transport can severely impact diagnostic reliability.

Key Market Trends

Automation and Digitalization in Specimen Handling

A key trend reshaping the virology specimen collection market is the adoption of automation and digital tools in specimen management. Automated systems reduce manual errors, maintain sample integrity, and streamline the overall process from collection to analysis. Technologies such as barcoded specimen tubes, automated swab collection, electronic order entry, and laboratory information management systems (LIMS) are enhancing operational efficiency. These innovations ensure chain-of-custody, improve tracking, and minimize contamination risks. During the COVID-19 crisis, digital health platforms enabled home-based sample collection and automatic result reporting to centralized databases, illustrating the scalability and effectiveness of integrated tech-enabled solutions in virology diagnostics.

Key Market Players

• Becton, Dickinson and Company
• Quidel Corporation
• Thermo Fisher Scientific Inc.
• Trinity Biotech PLC
• Titan Biotech Ltd.
• DiaSorin S.p.A.
• Vircell S.L.
• Copan Italia S.P.A.
• Puritan Medical Products Co.
• Hardy Diagnostics

Report Scope:

In this report, the Global Virology Specimen Collection Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Virology Specimen Collection Market, By Product Type:

• Viral Transport Media
• Specimen Collection Tubes
• Swabs
• Blood Collection Kits

Virology Specimen Collection Market, By Sample:

• Blood Samples
• Cervical Samples
• Nasal Samples
• Nasopharyngeal Samples
• Throat Samples
• Oral Samples
• Other Samples

Virology Specimen Collection Market, By Region:

• North America
  • United States
  • Mexico
  • Canada
• Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
• Asia-Pacific
  • China
  • India
  • South Korea
  • Japan
  • Australia
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Virology Specimen Collection Market.

Available Customizations:

Global Virology Specimen Collection Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Virology Specimen Collection Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product Type (Viral Transport Media, Specimen Collection Tubes, Swabs, Blood Collection Kits)
  • 5.2.2. By Sample (Blood Samples, Cervical Samples, Nasal Samples, Nasopharyngeal Samples, Throat Samples, Oral Samples, Other Samples)
  • 5.2.3. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
  • 5.2.4. By Company (2024)
• 5.3. Market Map
• 5.3.1 By Product Type
• 5.3.2 By Sample
• 5.3.3 By Region

6. North America Virology Specimen Collection Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product Type (Viral Transport Media, Specimen Collection Tubes, Swabs, Blood Collection Kits)
  • 6.2.2. By Sample (Blood Samples, Cervical Samples, Nasal Samples, Nasopharyngeal Samples, Throat Samples, Oral Samples, Other Samples)
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Virology Specimen Collection Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product Type
      • 6.3.1.2.2. By Sample
  • 6.3.2. Canada Virology Specimen Collection Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product Type
      • 6.3.2.2.2. By Sample
  • 6.3.3. Mexico Virology Specimen Collection Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product Type
      • 6.3.3.2.2. By Sample

7. Europe Virology Specimen Collection Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product Type (Viral Transport Media, Specimen Collection Tubes, Swabs, Blood Collection Kits)
  • 7.2.2. By Sample (Blood Samples, Cervical Samples, Nasal Samples, Nasopharyngeal Samples, Throat Samples, Oral Samples, Other Samples)
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Virology Specimen Collection Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product Type
      • 7.3.1.2.2. By Sample
  • 7.3.2. Germany Virology Specimen Collection Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product Type
      • 7.3.2.2.2. By Sample
  • 7.3.3. United Kingdom Virology Specimen Collection Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product Type
      • 7.3.3.2.2. By Sample
  • 7.3.4. Italy Virology Specimen Collection Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product Type
      • 7.3.4.2.2. By Sample
  • 7.3.5. Spain Virology Specimen Collection Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product Type
      • 7.3.5.2.2. By Sample

8. Asia-Pacific Virology Specimen Collection Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product Type (Viral Transport Media, Specimen Collection Tubes, Swabs, Blood Collection Kits)
  • 8.2.2. By Sample (Blood Samples, Cervical Samples, Nasal Samples, Nasopharyngeal Samples, Throat Samples, Oral Samples, Other Samples)
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Virology Specimen Collection Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product Type
      • 8.3.1.2.2. By Sample
  • 8.3.2. India Virology Specimen Collection Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product Type
      • 8.3.2.2.2. By Sample
  • 8.3.3. Japan Virology Specimen Collection Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product Type
      • 8.3.3.2.2. By Sample
  • 8.3.4. South Korea Virology Specimen Collection Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product Type
      • 8.3.4.2.2. By Sample
  • 8.3.5. Australia Virology Specimen Collection Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product Type
      • 8.3.5.2.2. By Sample

9. South America Virology Specimen Collection Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product Type (Viral Transport Media, Specimen Collection Tubes, Swabs, Blood Collection Kits)
  • 9.2.2. By Sample (Blood Samples, Cervical Samples, Nasal Samples, Nasopharyngeal Samples, Throat Samples, Oral Samples, Other Samples)
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Virology Specimen Collection Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product Type
      • 9.3.1.2.2. By Sample
  • 9.3.2. Argentina Virology Specimen Collection Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product Type
      • 9.3.2.2.2. By Sample
  • 9.3.3. Colombia Virology Specimen Collection Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product Type
      • 9.3.3.2.2. By Sample

10. Middle East and Africa Virology Specimen Collection Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product Type (Viral Transport Media, Specimen Collection Tubes, Swabs, Blood Collection Kits)
  • 10.2.2. By Sample (Blood Samples, Cervical Samples, Nasal Samples, Nasopharyngeal Samples, Throat Samples, Oral Samples, Other Samples)
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Virology Specimen Collection Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product Type
      • 10.3.1.2.2. By Sample
  • 10.3.2. Saudi Arabia Virology Specimen Collection Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product Type
      • 10.3.2.2.2. By Sample
  • 10.3.3. UAE Virology Specimen Collection Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product Type
      • 10.3.3.2.2. By Sample

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global Virology Specimen Collection Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Becton, Dickinson and Company
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Quidel Corporation
• 15.3. Thermo Fisher Scientific Inc.
• 15.4. Trinity Biotech PLC
• 15.5. Titan Biotech Ltd.
• 15.6. DiaSorin S.p.A.
• 15.7. Vircell S.L.
• 15.8. Copan Italia S.P.A.
• 15.9. Puritan Medical Products Co.
• 15.10. Hardy Diagnostics

16. Strategic Recommendations

17. About Us & Disclaimer